Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Can Alpha-Pinene Prevent Methotrexate-Induced Cardiac and Hepatic Damage

S. Cirrik, G. Hacioglu, E. Kabartan, B. Tezcan Yavuz, C. Sirin Tomruk

. 2024 ; 73 (4) : 621-631. [pub] 20240831

Status minimální Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24017602

The effects of alpha-pinene (AP), a monoterpenoid, known for its antioxidant, anti-inflammatory, and anti-apoptotic properties, on methotrexate (MTX)-induced cardiac and hepatic damage were investigated in this study. Male Sprague-Dawley rats were divided into Control, Vehicle, AP, MTX, and AP+MTX groups (n=7). AP (50 mg/kg/day, 14 days) was applied subcutaneously in the AP and AP+MTX groups. MTX (20 mg/kg) was injected three days before sacrification. Serum CK-MB, troponin T, ALT, and AST levels, as well as cardiac and hepatic MDA, GSH, caspase-3, and p53 levels, were measured by ELISA. Histological changes in tissues were evaluated by scoring in terms of tissue damage and cellular degeneration parameters after hematoxylin-eosin staining. MTX caused significant increase in serum CK-MB, troponin T, ALT, and AST levels, hepatic and cardiac lipid peroxidation, GSH depletion, and caspase-3 level. However, tissue levels of p53 did not change significantly. MTX-induced histological deterioration was observed in both tissues. These MTX-induced changes were significantly reduced in the AP+MTX group. Present results show that MTX-induced cardiac and hepatic damage is prevented by AP pretreatment. This protection can be attributed to the antioxidant and anti-apoptotic properties of AP. Considering the importance of MTX in cancer treatment, AP appears to have highly promising potential as a cardioprotective and hepatoprotective agent in anti-tumoral therapy. Key words: MDA, GSH, Caspase-3, p53, Oxidative stress, Apoptosis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24017602
003      
CZ-PrNML
005      
20250312151316.0
007      
ta
008      
241004s2024 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.935338 $2 doi
035    __
$a (PubMed)39264082
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Cirrik, S $u Ordu University, Medical Faculty, Physiology Department, Ordu, Turkiye
245    10
$a Can Alpha-Pinene Prevent Methotrexate-Induced Cardiac and Hepatic Damage / $c S. Cirrik, G. Hacioglu, E. Kabartan, B. Tezcan Yavuz, C. Sirin Tomruk
520    9_
$a The effects of alpha-pinene (AP), a monoterpenoid, known for its antioxidant, anti-inflammatory, and anti-apoptotic properties, on methotrexate (MTX)-induced cardiac and hepatic damage were investigated in this study. Male Sprague-Dawley rats were divided into Control, Vehicle, AP, MTX, and AP+MTX groups (n=7). AP (50 mg/kg/day, 14 days) was applied subcutaneously in the AP and AP+MTX groups. MTX (20 mg/kg) was injected three days before sacrification. Serum CK-MB, troponin T, ALT, and AST levels, as well as cardiac and hepatic MDA, GSH, caspase-3, and p53 levels, were measured by ELISA. Histological changes in tissues were evaluated by scoring in terms of tissue damage and cellular degeneration parameters after hematoxylin-eosin staining. MTX caused significant increase in serum CK-MB, troponin T, ALT, and AST levels, hepatic and cardiac lipid peroxidation, GSH depletion, and caspase-3 level. However, tissue levels of p53 did not change significantly. MTX-induced histological deterioration was observed in both tissues. These MTX-induced changes were significantly reduced in the AP+MTX group. Present results show that MTX-induced cardiac and hepatic damage is prevented by AP pretreatment. This protection can be attributed to the antioxidant and anti-apoptotic properties of AP. Considering the importance of MTX in cancer treatment, AP appears to have highly promising potential as a cardioprotective and hepatoprotective agent in anti-tumoral therapy. Key words: MDA, GSH, Caspase-3, p53, Oxidative stress, Apoptosis.
650    _2
$a zvířata $7 D000818
650    _2
$a mužské pohlaví $7 D008297
650    12
$a methotrexát $x toxicita $7 D008727
650    12
$a potkani Sprague-Dawley $7 D017207
650    _2
$a krysa rodu Rattus $7 D051381
650    12
$a bicyklické monoterpeny $x farmakologie $7 D000081008
650    _2
$a lékové postižení jater $x prevence a kontrola $x patologie $x metabolismus $7 D056486
650    _2
$a oxidační stres $x účinky léků $7 D018384
650    _2
$a antioxidancia $x farmakologie $7 D000975
650    _2
$a játra $x účinky léků $x patologie $x metabolismus $7 D008099
650    _2
$a myokard $x patologie $x metabolismus $7 D009206
650    _2
$a monoterpeny $x farmakologie $x terapeutické užití $7 D039821
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hacioglu, G
700    1_
$a Kabartan, E
700    1_
$a Tezcan Yavuz, B
700    1_
$a Sirin Tomruk, C
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 73, č. 4 (2024), s. 621-631
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39264082 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y - $z 0
990    __
$a 20241004 $b ABA008
991    __
$a 20250312151323 $b ABA008
999    __
$a min $b bmc $g 2283514 $s 1229552
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 73 $c 4 $d 621-631 $e 20240831 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
LZP    __
$a Pubmed-20241004

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...